Market Closed -
Hong Kong S.E.
04:08:13 2024-07-03 am EDT
|
5-day change
|
1st Jan Change
|
1.12
HKD
|
-1.75%
|
|
-3.45%
|
-50.66%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
9,322
|
9,760
|
7,847
|
4,875
|
2,631
|
1,353
|
-
|
-
|
Enterprise Value (EV)
1 |
6,607
|
6,792
|
7,250
|
4,544
|
1,954
|
789.7
|
891.3
|
480.9
|
P/E ratio
|
-3.85
x
|
-7.25
x
|
-
|
-5.31
x
|
-7.11
x
|
-26.5
x
|
-26.5
x
|
15.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
9.4
x
|
32.2
x
|
10.1
x
|
5.67
x
|
1.47
x
|
1.44
x
|
1.14
x
|
EV / Revenue
|
-
|
6.54
x
|
29.7
x
|
9.44
x
|
4.21
x
|
0.86
x
|
0.95
x
|
0.41
x
|
EV / EBITDA
|
-4.02
x
|
-6.31
x
|
-3.99
x
|
-5.09
x
|
-3.34
x
|
-14.5
x
|
-21.5
x
|
4.35
x
|
EV / FCF
|
-6,078,351
x
|
-11,810,660
x
|
-4,570,514
x
|
-7,418,360
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
3.58
x
|
3
x
|
6.63
x
|
10.9
x
|
5.7
x
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
1,012,681
|
1,150,415
|
1,164,452
|
1,192,099
|
1,275,317
|
1,275,344
|
-
|
-
|
Reference price
2 |
9.205
|
8.484
|
6.738
|
4.089
|
2.063
|
1.061
|
1.061
|
1.061
|
Announcement Date
|
3/26/20
|
3/25/21
|
6/8/22
|
4/26/23
|
4/23/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,039
|
243.7
|
481.4
|
463.8
|
922.8
|
942.3
|
1,186
|
EBITDA
1 |
-1,642
|
-1,077
|
-1,818
|
-892.9
|
-585.4
|
-54.4
|
-41.47
|
110.5
|
EBIT
1 |
-1,653
|
-1,092
|
-1,829
|
-912.1
|
-605.6
|
-85.02
|
-72.21
|
79.24
|
Operating Margin
|
-
|
-105.11%
|
-750.64%
|
-189.49%
|
-130.55%
|
-9.21%
|
-7.66%
|
6.68%
|
Earnings before Tax (EBT)
1 |
-2,308
|
-1,221
|
-1,920
|
-902.7
|
-367.2
|
-56.14
|
-48.77
|
104.8
|
Net income
1 |
-2,308
|
-1,221
|
-1,920
|
-902.7
|
-367.2
|
-56.14
|
-48.77
|
89.06
|
Net margin
|
-
|
-117.54%
|
-787.84%
|
-187.53%
|
-79.17%
|
-6.08%
|
-5.18%
|
7.51%
|
EPS
2 |
-2.390
|
-1.170
|
-
|
-0.7700
|
-0.2900
|
-0.0400
|
-0.0400
|
0.0700
|
Free Cash Flow
|
-1,087
|
-575.1
|
-1,586
|
-612.5
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-55.36%
|
-650.9%
|
-127.24%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/26/20
|
3/25/21
|
6/8/22
|
4/26/23
|
4/23/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
|
-
|
-
|
1,039
|
79.4
|
164.3
|
261.8
|
219.6
|
261.5
|
202.4
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-704
|
-1,125
|
-209.7
|
-533.4
|
-254
|
-351.6
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-886.62%
|
-685.14%
|
-80.11%
|
-242.89%
|
-97.13%
|
-173.74%
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
1 |
-
|
-
|
-
|
-
|
-
|
-0.3100
|
-0.4600
|
-0.1700
|
-0.1200
|
-0.1000
|
0.0600
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/26/20
|
8/18/20
|
3/25/21
|
8/26/21
|
6/8/22
|
9/23/22
|
4/26/23
|
8/15/23
|
4/23/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
2,715
|
2,968
|
596
|
331
|
678
|
563
|
462
|
872
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-1,087
|
-575
|
-1,586
|
-612
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-154%
|
-44.9%
|
-92.3%
|
-109%
|
-81.1%
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-101%
|
-36.4%
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
2,289
|
3,357
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
2.570
|
2.820
|
1.020
|
0.3700
|
0.3600
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-0.4900
|
-1.280
|
-
|
-
|
-
|
-
|
-
|
Capex
|
6.21
|
67
|
91
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
6.45%
|
37.35%
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/26/20
|
3/25/21
|
6/8/22
|
4/26/23
|
4/23/24
|
-
|
-
|
-
|
Last Close Price
1.061
CNY Average target price
2.698
CNY Spread / Average Target +154.33% Consensus |
1st Jan change
|
Capi.
|
---|
| -50.66% | 186M | | +16.44% | 122B | | +18.94% | 113B | | +18.92% | 26.22B | | -25.37% | 19.01B | | -19.74% | 15.71B | | -20.20% | 15.22B | | -47.37% | 14.72B | | +59.91% | 14.58B | | +4.35% | 13.84B |
Bio Therapeutic Drugs
|